These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 18163955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of collagen-induced arthritis by DNA vaccines encoding TCR Vbeta5.2 and TCR Vbeta8.2.
    Ge PL, Ma LP, Wang W, Li Y, Zhao WM.
    Chin Med J (Engl); 2009 May 05; 122(9):1039-48. PubMed ID: 19493438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clonotypic analysis of T cells accumulating at arthritic lesions in HTLV-I env-pX transgenic rats.
    Sugaya T, Ishizu A, Ikeda H, Nakamaru Y, Fugo K, Higuchi M, Yamazaki H, Imai K, Yoshiki T.
    Exp Mol Pathol; 2002 Feb 05; 72(1):56-61. PubMed ID: 11784123
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
    Quintana FJ, Carmi P, Mor F, Cohen IR.
    Arthritis Rheum; 2004 Nov 05; 50(11):3712-20. PubMed ID: 15529360
    [Abstract] [Full Text] [Related]

  • 7. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.
    Clin Immunol; 2007 Jan 05; 122(1):75-84. PubMed ID: 17045846
    [Abstract] [Full Text] [Related]

  • 8. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
    Mukherjee P, Yang SY, Wu B, Song Z, Myers LK, Robbins PD, Wooley PH.
    Ann Rheum Dis; 2005 Nov 05; 64(11):1550-6. PubMed ID: 15860512
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
    Arthritis Rheum; 2006 Aug 05; 54(8):2423-33. PubMed ID: 16869010
    [Abstract] [Full Text] [Related]

  • 13. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice.
    Anthony DD, Heeger PS, Haqqi TM.
    Clin Exp Rheumatol; 2001 Aug 05; 19(4):385-94. PubMed ID: 11491493
    [Abstract] [Full Text] [Related]

  • 14. Tolerizing DNA vaccines for autoimmune arthritis.
    Ho PP, Higgins JP, Kidd BA, Tomooka B, Digennaro C, Lee LY, de Vegvar HE, Steinman L, Robinson WH.
    Autoimmunity; 2006 Dec 05; 39(8):675-82. PubMed ID: 17178564
    [Abstract] [Full Text] [Related]

  • 15. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T.
    Arthritis Rheum; 2009 Aug 05; 60(8):2294-303. PubMed ID: 19644886
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
    Honda A, Ametani A, Matsumoto T, Iwaya A, Kano H, Hachimura S, Ohkawa K, Kaminogawa S, Suzuki K, Sercarz EE, Kumar V.
    Int Immunol; 2004 May 05; 16(5):737-45. PubMed ID: 15096482
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Song X, Liang F, Liu N, Luo Y, Xue H, Yuan F, Tan L, Sun Y, Xi C, Xi Y.
    Vaccine; 2009 Jan 29; 27(5):690-700. PubMed ID: 19095031
    [Abstract] [Full Text] [Related]

  • 20. Dominant and shared T cell receptor beta chain variable regions of T cells inducing synovial hyperplasia in rheumatoid arthritis.
    Mima T, Ohshima S, Sasai M, Nishioka K, Shimizu M, Murata N, Yasunami R, Matsuno H, Suemura M, Kishimoto T, Saeki Y.
    Biochem Biophys Res Commun; 1999 Sep 16; 263(1):172-80. PubMed ID: 10486273
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.